Intravoxel Incoherent Motion MR Imaging in the Differentiation of Benign and Malignant Sinonasal Lesions: Comparison with Conventional Diffusion-Weighted MR Imaging

References

1. 1.↵
   2. Slootweg PJ,
   3. Ferlito A,
   4. Cardesa A, et al

   . Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol 2013;270:5–20 doi:10.1007/s00405-012-2025-4 pmid:22610012

   CrossRefPubMed
2. 2.↵
   2. Su SY,
   3. Kupferman ME,
   4. DeMonte F, et al

   . Endoscopic resection of sinonasal cancers. Curr Oncol Rep 2014;16:369 doi:10.1007/s11912-013-0369-6 pmid:24445501

   CrossRefPubMed
3. 3.↵
   2. Eggesbø HB

   . Imaging of sinonasal tumours. Cancer Imaging 2012;12:136–52 doi:10.1102/1470-7330.2012.0015 pmid:22571851

   CrossRefPubMed
4. 4.↵
   2. Koeller KK

   . Radiologic features of sinonasal tumors. Head Neck Pathol 2016;10:1–12 doi:10.1007/s12105-016-0686-9 pmid:26830408

   CrossRefPubMed
5. 5.↵
   2. Wang XY,
   3. Yan F,
   4. Hao H, et al

   . Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging. Chin Med J (Engl) 2015;128:586–92 doi:10.4103/0366-6999.151649 pmid:25698188

   CrossRefPubMed
6. 6.↵
   2. Jégoux F,
   3. Metreau A,
   4. Louvel G, et al

   . Paranasal sinus cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2013;130:327–35 doi:10.1016/j.anorl.2012.07.007 pmid:23523040

   CrossRefPubMed
7. 7.↵
   2. Carta F,
   3. Blancal JP,
   4. Verillaud B, et al

   . Surgical management of inverted papilloma: approaching a new standard for surgery. Head Neck 2013;35:1415–20 doi:10.1002/hed.23159 pmid:23002029

   CrossRefPubMed
8. 8.↵
   2. Madani G,
   3. Beale TJ,
   4. Lund VJ

   . Imaging of sinonasal tumors. Semin Ultrasound CT MR 2009;30:25–38 doi:10.1053/j.sult.2008.10.013 pmid:19388236

   CrossRefPubMed
9. 9.↵
   2. Sasaki M,
   3. Eida S,
   4. Sumi M, et al

   . Apparent diffusion coefficient mapping for sinonasal diseases: differentiation of benign and malignant lesions. AJNR Am J Neuroradiol 2011;32:1100–06 doi:10.3174/ajnr.A2434 pmid:21393402

   Abstract/FREE Full Text
10. 10.↵
    2. Sasaki M,
    3. Sumi M,
    4. Eida S, et al

    . Multiparametric MR imaging of sinonasal diseases: time-signal intensity curve- and apparent diffusion coefficient-based differentiation between benign and malignant lesions. AJNR Am J Neuroradiol 2011;32:2154–59 doi:10.3174/ajnr.A2675 pmid:21920869

    Abstract/FREE Full Text
11. 11.↵
    2. White ML,
    3. Zhang Y,
    4. Robinson RA

    . Evaluating tumors and tumorlike lesions of the nasal cavity, the paranasal sinuses, and the adjacent skull base with diffusion-weighted MRI. J Comput Assist Tomogr 2006;30:490–95 doi:10.1097/00004728-200605000-00023 pmid:16778627

    CrossRefPubMed
12. 12.↵
    2. Wang F,
    3. Sha Y,
    4. Zhao M, et al

    . High-resolution diffusion-weighted imaging improves the diagnostic accuracy of dynamic contrast-enhanced sinonasal magnetic resonance imaging. J Comput Assist Tomogr 2017;41:199–205 doi:10.1097/RCT.0000000000000502 pmid:27560026

    CrossRefPubMed
13. 13.↵
    2. Le Bihan D

    . Intravoxel incoherent motion imaging using steady-state free precession. Magn Reson Med 1988;7:346–51 doi:10.1002/mrm.1910070312 pmid:3205150

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Le Bihan D,
    3. Breton E,
    4. Lallemand D, et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07 doi:10.1148/radiology.161.2.3763909 pmid:3763909

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Iima M,
    3. Le Bihan D

    . Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology 2016;278:13–32 doi:10.1148/radiol.2015150244 pmid:26690990

    CrossRefPubMed
16. 16.↵
    2. Fujima N,
    3. Yoshida D,
    4. Sakashita T, et al

    . Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI. Magn Reson Imaging 2014;32:1206–13 doi:10.1016/j.mri.2014.08.009 pmid:25131628

    CrossRefPubMed
17. 17.↵
    2. Sumi M,
    3. Nakamura T

    . Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model. AJNR Am J Neuroradiol 2013;34:410–16 doi:10.3174/ajnr.A3227 pmid:22859281

    Abstract/FREE Full Text
18. 18.↵
    2. Jia QJ,
    3. Zhang SX,
    4. Chen WB, et al

    . Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma. Eur Radiol 2014;24:3076–87 doi:10.1007/s00330-014-3343-2 pmid:25052079

    CrossRefPubMed
19. 19.↵
    2. Lai V,
    3. Li X,
    4. Lee VH, et al

    . Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging. Eur Radiol 2014;24:176–83 doi:10.1007/s00330-013-2995-7 pmid:23990005

    CrossRefPubMed
20. 20.↵
    2. Hauser T,
    3. Essig M,
    4. Jensen A, et al

    . Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur J Radiol 2014;83:783–87 doi:10.1016/j.ejrad.2014.02.013 pmid:24631600

    CrossRefPubMed
21. 21.↵
    2. Fujima N,
    3. Yoshida D,
    4. Sakashita T, et al

    . Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients. Eur Radiol 2017;27:956–65 doi:10.1007/s00330-016-4440-1 pmid:27255401

    CrossRefPubMed
22. 22.↵
    2. Sumi M,
    3. Van Cauteren M,
    4. Sumi T, et al

    . Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012;263:770–77 doi:10.1148/radiol.12111248 pmid:22447854

    CrossRefPubMed
23. 23.↵
    2. Le Bihan D

    . Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995;8:375–86 doi:10.1002/nbm.1940080711 pmid:8739274

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Jung Y,
    3. Hu J

    . A K-fold averaging cross-validation procedure. J Nonparametr Stat 2015;27:167–79 doi:10.1080/10485252.2015.1010532 pmid:27630515

    CrossRefPubMed
25. 25.↵
    2. Jiang JX,
    3. Tang ZH,
    4. Zhong YF, et al

    . Diffusion kurtosis imaging for differentiating between the benign and malignant sinonasal lesions. J Magn Reson Imaging 2017;45:1446–54 doi:10.1002/jmri.25500 pmid:27758016

    CrossRefPubMed
26. 26.↵
    2. Bridge JA,
    3. Bowen JM,
    4. Smith RB

    . The small round blue cell tumors of the sinonasal area. Head Neck Pathol 2010;4:84–93 doi:10.1007/s12105-009-0158-6 pmid:20237994

    CrossRefPubMed
27. 27.↵
    2. Thoeny HC,
    3. De Keyzer F,
    4. Boesch C, et al

    . Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004;20:786–90 doi:10.1002/jmri.20196 pmid:15503336

    CrossRefPubMed
28. 28.↵
    2. Padhani AR,
    3. Liu G,
    4. Koh DM, et al

    . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–25 doi:10.1593/neo.81328 pmid:19186405

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Suo S,
    3. Lin N,
    4. Wang H, et al

    . Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 Tesla: comparison of different curve-fitting methods. J Magn Reson Imaging 2015;42:362–70 doi:10.1002/jmri.24799 pmid:25407944

    CrossRefPubMed
30. 30.↵
    2. Sasaki M,
    3. Sumi M,
    4. Eida S, et al

    . Simple and reliable determination of intravoxel incoherent motion parameters for the differential diagnosis of head and neck tumors. PLoS One 2014;9:e112866 pmid:1371/journal.pone.0112866pmid:25402436

    CrossRefPubMed
31. 31.↵
    2. Liu C,
    3. Wang K,
    4. Chan Q, et al

    . Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging. Eur Radiol 2016;26:3888–98 doi:10.1007/s00330-016-4241-6 pmid:26863896

    CrossRefPubMed
32. 32.↵
    2. Pang Y,
    3. Turkbey B,
    4. Bernardo M, et al

    . Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 2013;69:553–62 doi:10.1002/mrm.24277 pmid:22488794

    CrossRefPubMed
33. 33.↵
    2. Lee HJ,
    3. Rha SY,
    4. Chung YE, et al

    . Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: correlation with histological microvessel density. Magn Reson Med 2014;71:1554–58 doi:10.1002/mrm.24810 pmid:23798038

    CrossRefPubMed
34. 34.↵
    2. Wang LL,
    3. Lin J,
    4. Liu K, et al

    . Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging. Eur Radiol 2014;24:1914–22 doi:10.1007/s00330-014-3176-z pmid:24788038

    CrossRefPubMed
35. 35.↵
    2. Iima M,
    3. Yano K,
    4. Kataoka M, et al

    . Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions. Invest Radiol 2015;50:205–11 doi:10.1097/RLI.0000000000000094 pmid:25260092

    CrossRefPubMed
36. 36.↵
    2. Kim B,
    3. Lee SS,
    4. Sung YS, et al

    . Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: characterization of benign and malignant pancreatic pathologies. J Magn Reson Imaging 2017;45:260–69 doi:10.1002/jmri.25334 pmid:27273754

    CrossRefPubMed
37. 37.↵
    2. Le Bihan D,
    3. Turner R

    . The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992;27:171–78 doi:10.1002/mrm.1910270116 pmid:1435202

    CrossRefPubMed
38. 38.↵
    2. Lewin M,
    3. Fartoux L,
    4. Vignaud A, et al

    . The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 2011;21:281–90 doi:10.1007/s00330-010-1914-4 pmid:20683597

    CrossRefPubMed
39. 39.↵
    2. Xian J,
    3. Du H,
    4. Wang X, et al

    . Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors. Chin Med J (Engl) 2014;127:2259–64 pmid:24931238

    PubMed
40. 40.↵
    2. Liu C,
    3. Liang C,
    4. Liu Z, et al

    . Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI. Eur J Radiol 2013;82:e782–89 doi:10.1016/j.ejrad.2013.08.006 pmid:24034833

    CrossRefPubMed
41. 41.↵
    2. Lu P,
    3. Sha Y,
    4. Wan H, et al

    . Assessment of nonarteritic anterior ischemic optic neuropathy with intravoxel incoherent motion diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging, and 2D navigator-based reacquisition. J Magn Reson Imaging 2017;46:1760–66 doi:10.1002/jmri.25760 pmid:28513892

    CrossRefPubMed